A multicenter observational real practice study to evaluate the persistence with denosumab treatment in post-menopausal women affected by osteoporosis with fragility fractures
Latest Information Update: 14 Jun 2017
Price :
$35 *
At a glance
- Drugs Denosumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 14 Jun 2017 New trial record
- 06 Jun 2017 Results published in the Journal of Endocrinological Investigation